Key points are not available for this paper at this time.
are promising SCLC biomarkers and therapeutic targets, providing clues to unravel ferroptosis-antigen presentation associations in tumor cells and optimize immunotherapeutic strategies.
Cai et al. (Wed,) studied this question.